FDA Drugs recall ·
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL)… recall
- Recall number
- D-0552-2026
- Date
- (initiated May 18, 2026)
- Company / brand
- Eugia US LLC
279 Princeton Hightstown Rd, East Windsor, NJ, United States - Category
- Drugs › Class III
- Classification
- Class III
- Status
- Ongoing
- Units affected
- 168,300 vials
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02
Why was it recalled?
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029
Distribution
US Nationwide.
What does Class III mean?
Class III means use of or exposure to the product is not likely to cause adverse health consequences (for example, a labeling violation).
Source: FDA (drugs), recall D-0552-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.